T. Rowe Price Investment Management, Inc. Immunome Inc. Transaction History
T. Rowe Price Investment Management, Inc.
- $166 Billion
- Q3 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Immunome Inc. stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 5,762,013 shares of IMNM stock, worth $54.6 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
5,762,013
Previous 3,878,595
48.56%
Holding current value
$54.6 Million
Previous $46.9 Million
79.5%
% of portfolio
0.05%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding IMNM
# of Institutions
122Shares Held
47.1MCall Options Held
322KPut Options Held
1.91M-
Redmile Group, LLC San Francisco, CA4.89MShares$46.4 Million4.67% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.88MShares$36.8 Million2.46% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$35.6 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X03.49MShares$33.1 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.13MShares$29.7 Million0.0% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $115M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...